Your browser doesn't support javascript.
loading
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy.
Williams, Daniel M; Hornsby, Hailey R; Shehata, Ola M; Brown, Rebecca; Gallis, Marta; Meardon, Naomi; Newman, Thomas A H; Plowright, Megan; Zafred, Domen; Shun-Shion, Amber S M; Hodder, Anthony J; Bliss, Deepa; Metcalfe, Andrew; Edgar, James R; Gordon, David E; Sayers, Jon R; Nicklin, Martin J; Carroll, Miles; Collini, Paul J; Brown, Stephen; de Silva, Thushan I; Peden, Andrew A.
Affiliation
  • Williams DM; School of Bioscience, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
  • Hornsby HR; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Shehata OM; School of Bioscience, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
  • Brown R; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Gallis M; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Meardon N; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Newman TAH; South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK.
  • Plowright M; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Zafred D; South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK.
  • Shun-Shion ASM; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Hodder AJ; South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK.
  • Bliss D; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Metcalfe A; School of Bioscience, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
  • Edgar JR; School of Bioscience, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
  • Gordon DE; School of Bioscience, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
  • Sayers JR; School of Bioscience, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
  • Nicklin MJ; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
  • Carroll M; Department of Pathology, Emory University, Whitehead Building, Atlanta, GA, USA.
  • Collini PJ; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
  • Brown S; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
  • Peden AA; Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
iScience ; 26(7): 107056, 2023 Jul 21.
Article de En | MEDLINE | ID: mdl-37346049
ABSTRACT
The prevalence and strength of serological responses mounted toward SARS-CoV-2 proteins other than nucleocapsid (N) and spike (S), which may be of use as additional serological markers, remains underexplored. Using high-content microscopy to assess antibody responses against full-length StrepTagged SARS-CoV-2 proteins, we found that 85% (166/196) of unvaccinated individuals with RT-PCR confirmed SARS-CoV-2 infections and 74% (31/42) of individuals infected after being vaccinated developed detectable IgG against the structural protein M, which is higher than previous estimates. Compared with N antibodies, M IgG displayed a shallower time-dependent decay and greater specificity. Sensitivity for SARS-CoV-2 seroprevalence was enhanced when N and M IgG detection was combined. These findings indicate that screening for M seroconversion may be a good approach for detecting additional vaccine breakthrough infections and highlight the potential to use HCM as a rapidly deployable method to identify the most immunogenic targets of newly emergent pathogens.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: IScience Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: IScience Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni